Reneuron Share Discussion Threads

[1stocktracker] 16/12/2022 15:17

Just bought more as the herd are arriving £6m mkt cap no brainer
Group ended the period with cash, cash equivalents and bank deposits of £10.5 million and with our cash runway being extended until at least the start of the fourth calendar quarter 2023 and the right team now in place, the Company will look to build on these foundations and sign new longer-term commercial partnerships to further extend the cash runway and therefore deliver value commensurate with what our CustomExTM platform can offer in the field of targeted drug delivery

From what I can see, the major shareholder is completely out and RENE is at three year lows with cash until 2023/24

[itsmyshares] 12/12/2022 18:45

Cash of 10m and market cap is 6.13m. I feel a huge bounce is on the cards.

[terminator101] 12/12/2022 18:02

I suggested back in February (#8334) that RG was selling and the delusional clowns on this board dismissed it.

I see that the “seller out” “its amazing value” “big bounce from here” waffle has already started. However, this is still a pile of pedestrian pish that has lost its biggest shareholder. Nothings changed, why would it be anymore of a buy than yesterday?

[manual dexterity] 12/12/2022 16:22

That may well be the last of it.

[lovewinshatelosses] 12/12/2022 14:42

There we go - RG nearly out. Hopefully the other major holders will give Iain more time to hopefully provide that shareholder value that was promised :)

[deutsch4] 12/12/2022 11:21

Where monkeys stuff there nuts -Boyo!

[stutes] 10/12/2022 06:01

The market cap is between £6m to £7m ye the company has £10m at the bank and Fosun could pay circa £70m for stroke/retina treatment, subject o trials.

It looks as if City has lost faith in Rene to deliver?

[lovewinshatelosses] 08/12/2022 09:27

Nice to see some newsflow here today. Without some chunky inside buying however, it signifies nothing. Come on, Iain, make a big statement with an even bigger share purchase!

[small crow] 07/12/2022 17:52

Interesting times.

[lovewinshatelosses] 07/12/2022 11:58

I suspect RG is selling up. Maybe some of the other main holders too. Cannot imagine the share price action the last few days is the result of PI selling. No inside buying either, which is a shame, as I had high hopes that Iain would be different to so many of the other AIM CEOs. Oh well, we shall see how this plays out.

[blackhorse23] 06/12/2022 21:22

Placing any moment , cash running out . Bought today CURY (LSE) which looks rewarding buy

[small crow] 06/12/2022 18:20

I suspect news here soon. Probably good.

[terminator101] 06/12/2022 14:04

Oh dear, down again for this pile of pedestrian pish.

[volsung] 02/12/2022 16:37

Pharma is dead.
Covid killed it

[digger2779] 02/12/2022 16:26

£10 million left in the kitty. Merry crimble to be had by the bod.

[lovewinshatelosses] 02/12/2022 12:47

Some big inside buying here is required. Enough time to get a deal still before the cash runs out, but unless we do see some Director pockets being opened, why should any PI's do so? GLA.

[algernon2] 02/12/2022 12:30

Where's the switch?!

[scepticalinvestor] 02/12/2022 08:58

BargepoleLast one leaving, turn out the lights

[adw198] 02/12/2022 07:51

Yep very concerning statement. Not much in there to think they’ve got anything imminent by way of deals. Suspect we’ll have a quite a bad reaction

The very limited Director buying was a bit of a red flag but I didn’t follow my instincts

[terminator101] 02/12/2022 07:11

Well after all that waffle on here that their cash runway was perfectly fine, it seems that the pedestrian scientists WERE out looking for cash. They have put that off as the “Board has concluded that it will not be possible to complete an equity raise at the current time” which basically means they haven’t got a good story to sell to the markets.

Does anyone think that putting it off by doing some dodgy cashflow and depleting their cash any further so that they are totally desperate for cash next year is going to make it any better? If you do then good luck with that.

[blackhorse23] 11/11/2022 09:00

Yesterday bought some MCL (LSE) , good news coming next week

[terminator101] 06/11/2022 17:36

That’s a lie mate, the reduced cash burn has already been taken into account in the assessment. Check the interims.

This pedestrian fluff has a material uncertainty as to it being a going concern hanging over it like a sword of Damocles. The next fundraising will be brutal.

😳😳😳😳8563;😳ԅ63;

The Group is expected to incur further costs as it continues to develop its technologies through the research and pre-clinical development pathway. The operations of the Group are currently being financed from funds that have been raised from share placings, commercial partnerships and grants.

The Group actively seeks further business development and commercial opportunities to support its ongoing development programmes. The Board places considerable emphasis on communication with shareholders, potential investors and other commercial organisations in order to maximise the chances of success in exploiting these opportunities. Following a strategic decision, it was announced in January 2022 that the internal development of the Group's hRPC programme would be halted, with existing resources refocused on the Group's exosome technology platform extending the companies cash runway. It is considered that this strategy provides the best opportunity to create increasing and sustainable shareholder value.

Based on the above, the Directors expect that the Group's current financial resources will be sufficient to support the business until at least mid-2023 and the Directors continue to seek opportunities to secure further revenues / funding sufficient for the future needs of the business beyond mid-2023.

The Directors therefore consider it appropriate to continue to adopt the going concern basis in the preparation of these financial statements. However, there is no guarantee that attempts to secure adequate additional revenues / funding on a timely basis will be successful and therefore this represents a material uncertainty, which may cast significant doubt about the Group's and Company's ability to continue as a going concern. These financial statements do not include the adjustments that would result if the Group were unable to continue as a going concern.

[gotabsirius] 03/11/2022 18:28

Already been reduced. Cash runway now into 2024...